Finance

Beta
Lists
688767:SHA
Hangzhou Biotest Biotech Co Ltd
CNÂ¥38.05
-0.81%
(-0.31) 1D
Jun 12, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688767...
Open
CNÂ¥38.88
High
CNÂ¥39.25
Low
CNÂ¥37.40
Mkt. cap
5.68B
Avg. vol.
3.39M
Volume
3.66M
Dividend
1.84%
Quarterly dividend
CNÂ¥0.17
Ex-dividend date
Jun 1, 2026
P/E ratio
129.63
52-wk high
CNÂ¥50.98
52-wk low
CNÂ¥30.40
EPS
CNÂ¥0.29
No. of employees
613
Open
CNÂ¥38.88
High
CNÂ¥39.25
Low
CNÂ¥37.40
Mkt. cap
5.68B
Avg. vol.
3.39M
Volume
3.66M
Dividend
1.84%
Quarterly dividend
CNÂ¥0.17
Ex-dividend date
Jun 1, 2026
P/E ratio
129.63
52-wk high
CNÂ¥50.98
52-wk low
CNÂ¥30.40
EPS
CNÂ¥0.29
No. of employees
613
News stories
From sources across the web
About Hangzhou Biotest Biotech Co Ltd
CEO-
Employees613
FoundedNov 28, 2008
Headquarters-
SectorBiotechnology
Websitebiotests.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
115.39M
104.79M
139.94M
89.38M
Cost of goods sold
61.61M
56.57M
82.06M
46.87M
Cost of revenue
61.61M
56.57M
82.06M
46.87M
Research and development expenses
24.87M
17.69M
25.80M
21.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.97M
23.98M
18.04M
23.38M
Operating expense
58.63M
40.49M
48.57M
46.96M
Total operating expenses
120.24M
97.06M
130.63M
93.84M
Operating income
-4.85M
7.73M
9.31M
-4.46M
Other non operating income
-193.37K
-10.56M
10.07M
-18.90M
EBT including unusual items
3.08M
10.18M
26.95M
-14.42M
EBT excluding unusual items
959.08K
13.20M
7.31M
-14.75M
Income tax expense
-8.05K
537.72K
210.51K
-3.89M
Effective tax rate
-0.26%
5.28%
0.78%
26.98%
Other operating expenses
2.37M
-1.73M
4.28M
1.79M
Net income
3.67M
9.86M
26.99M
-10.21M
Net profit margin
3.18%
9.41%
19.29%
-11.42%
Earnings per share
-
-
-
-
Interest and investment income
7.89M
14.14M
9.78M
8.60M
Interest expense
-
-
-
-
Net interest expenses
7.89M
14.14M
9.78M
8.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.18M
13.05M
15.31M
1.54M
Gain or loss from assets sale
-278.16K
278.16K
-247.49K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer